Author Topic: MS endophenotypes ID'd by high-dimensional blood signatures are associated w/distinct disease trajectories  (Read 3 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9822
  • MS diagnosed 1980
  • Location: Pacific Northwest
From Science Translational Medicine, one of the publications of the AAAS (March 27, 2024)--"Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories":


https://www.science.org/doi/10.1126/scitranslmed.ade8560


An article about this--GenomeWeb (March 27, 2024)--"Multiple sclerosis progression, disease response informed by blood-based signatures":


https://www.genomeweb.com/proteomics-protein-research/multiple-sclerosis-progression-disease-response-informed-blood-based



« Last Edit: Today at 08:25:26 am by agate »
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
112 Views
Last post April 16, 2017, 02:48:49 pm
by agate
1 Replies
147 Views
Last post December 04, 2017, 04:19:12 pm
by agate
0 Replies
76 Views
Last post July 28, 2019, 10:08:46 pm
by agate
0 Replies
32 Views
Last post March 13, 2021, 11:03:14 am
by agate
0 Replies
16 Views
Last post September 14, 2023, 09:19:26 pm
by agate